As scientists searched for patterns in who fell ill during the early pandemic, a large genetic study offered a quiet but telling signal: blood type, that ancient biological classification, appeared to carry a modest influence over COVID-19 susceptibility. 23andMe's analysis of over one million participants found that people with type O blood were measurably less likely to test positive, while type A individuals showed greater vulnerability — a difference possibly rooted in how certain antibodies interact with the virus. Yet the study's most sobering finding had nothing to do with blood: Africa
IFLScience
· Sep 25, 2020
· health
· 3 min de lectura
Medium
Verificación: Caracterizado
Study Links Blood Type O to Lower COVID-19 Risk, Type A to Higher Vulnerability
African Americans and Latino populations show disproportionate COVID-19 hospitalization rates, with Black patients nearly twice as likely to require hospitalization than white patients.
◉
Health & Medicine
8098 artículos relacionados
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 100% coincidencia
Blood test could predict Covid-19 mortality risk, study finds
BreakingNews.ie · 99% coincidencia
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% coincidencia
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% coincidencia
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% coincidencia
Cobertura Relacionada
The Guardian · Aug 20
Hundreds of thousands await GCSE results as gender gap narrows to 10-year low
Hundreds of thousands of UK students received GCSE results showing overall grade improvements in 2025, with the gender g…
The Straits Times · Aug 20 Ebola spreads beyond Congo epicentre, overwhelming treatment capacityEbola cases in DRC are accelerating outside the initial Ituri epicenter, with North Kivu and Haut-Uélé provinces experie…
Science Daily · Aug 20 1,000+ genetic switches explain why women face higher autoimmune disease riskResearchers identified over 1,000 genetic switches that function differently in male and female immune cells, explaining…
News-Medical · Aug 20 Brain's Local Wiring May Buffer Cognitive Decline in Older AdultsUSC researchers found that white matter integrity helps protect cognitive function in older adults by compensating for g…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
This is a medical/scientific study about COVID-19 susceptibility by blood type, not a geopolitical matter requiring international relations analysis.
Escalation Risk
low
Confidence
HIGH
Lente Económico
📈
Genetic study links blood type O to 9-18% lower COVID-19 infection risk and type A to higher vulnerability, with implications for personalized medicine and healthcare resource allocation.
Market Signal
neutral
Confidence
LOW
Healthcare and pharmaceuticals
Genetic testing and biotechnology
Insurance and risk assessment
Medical device manufacturing
Public health services
Consumers may seek blood type testing for COVID-19 risk assessment, potentially increasing demand for genetic testing services. Those with type A blood may experience higher insurance premiums or healthcare costs if findings influence underwriting practices. Disparities highlighted may drive targeted public health interventions in Black and Latino communities.
Regulatory bodies may require peer-review validation before clinical application. Healthcare systems could implement blood-type stratified treatment protocols. Insurance regulators may need to address genetic discrimination concerns. Public health agencies may allocate resources based on population blood type distributions and documented racial disparities.